DDDijun Du

Dijun Du

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dijun Du has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A model for drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly

    by Zhaojun Zhong, Tuerxunjiang Maimaiti, Matthew L. Jackson, Rui Dong, Xueyan Gao, Qing Ouyang, Wenqian Wang, Jinliang Guo, Shangrong Li, Wenyu Shang, et al.

    Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the cell envelope, often via an indirect stepwise process. The major facilitator superfamily (MFS)-type tripartite efflux pumps use proton electrochemical gradient to extrude drugs in diverse bacterial species, but the architecture of the assembly and structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a distinct, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1 and contacts that are essential for the pump assembly. Key residues involved in drug transport are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The structural and functional data support a model for one-step drug transport by the MFS pump across the entire envelope of Gram-negative bacteria.


  • Open Access

    One-step drug transport across two membranes of Gram-negative bacteria by an MFS tripartite assembly

    by Ben Luisi, Dijun Du, Yanjie Chao, Zhaojun Zhong, Tuerxunjiang Maimaiti, Matthew Jackson, Rui Dong, Xueyan Gao, Jinliang Guo, Shangrong Li, et al.

    Transport of proteins and small molecules across cellular membrane is crucial for bacterial interaction with the environment and survival against antibiotics. In Gram-negative bacteria that possess two layers of membranes, specialized macromolecular machines are required to transport substrates across the envelope, often via an indirect stepwise procedure. The major facilitator superfamily (MFS)-type tripartite efflux pumps and type I secretion systems likely employ a direct one-step transport approach, but the structural mechanisms remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates resistance to multiple antimicrobial drugs through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we report the high-resolution (3.13 Å) structure of the EmrAB-TolC pump, revealing a unique, asymmetric architecture emerging from the assembly of TolC:EmrA:EmrB with a ratio of 3:6:1. This structure reveals two critical subdomains AssA and AssB that are essential for the pump assembly. Key residues involved in drug recognition, proton translocation and coupling are identified and corroborated by mutagenesis and antibiotic sensitivity assays. The delineation of the complete translocation pathway unravels the one-step drug transport mechanism of the MFS pump across the entire envelope of Gram-negative bacteria.

  • Open Access

    Structural transition of GP64 triggered by a pH-sensitive multi-histidine switch

    by Jinliang Guo, Shangrong Li, Lisha Bai, Huimin Zhao, Wenyu Shang, Zhaojun Zhong, Tuerxunjiang Maimaiti, Xueyan Gao, Ning Ji, Yanjie Chao, et al.

    The fusion of viruses with cellular membranes is a critical step in the life cycle of enveloped viruses. This process is facilitated by viral fusion proteins, many of which are conformationally pH-sensitive. The specifics of how changes in pH initiate this fusion have remained largely elusive. This study presents the cryo-electron microscopy (cryo-EM) structures of a prototype class III fusion protein, GP64, in its prefusion and early intermediate states, revealing the structural intermediates accompanying the membrane fusion process. The structures identify the involvement of a pH-sensitive switch, comprising H23, H245, and H304, in sensing the low pH that triggers the initial step of membrane fusion. The pH sensing role of this switch is corroborated by assays of cell-cell syncytium formation and dual dye-labeling. The findings demonstrate that coordination between multiple histidine residues acts as a pH sensor and activator. The involvement of a multi-histidine switch in viral fusion is applicable to fusogens of human-infecting thogotoviruses and other viruses, which could lead to strategies for developing anti-viral therapies and vaccines.


  • Open Access

    One-step drug transport across two membranes of Gram-negative bacteria

    by Ben Luisi, Zhaojun Zhong, Tuerxunjiang Maimaiti, Xueyan Gao, Rui Dong, Matthew Jackson, Wenyu Shang, Hongnian Jiang, Jinliang Guo, Shangrong Li, et al.

    Transport of proteins and small molecules across the complex cell envelope of Gram-negative bacteria is crucial for their survival and interaction with their environment and is facilitated by specialized macromolecular machines that enable direct one-step or indirect two-step translocation of substrates. Major facilitator superfamily (MFS)-type tripartite efflux pumps and type I secretion systems likely employ a similar one-step mechanism for substrate transport across cell membranes, but the structural details remain elusive. A representative MFS-type tripartite efflux pump, EmrAB-TolC, mediates multidrug resistance through proton-coupled EmrB, a member of the DHA2 transporter family. Here, we demonstrate that the EmrAB-TolC pump confers resistance to clinical antibiotics, including polymyxin B and neomycin, and report the high-resolution (3.11 Å) structure of the pump, revealing a unique, asymmetric architecture emerging from the TolC:EmrA:EmrB ratio of 3:6:1. This structure identifies two critical subdomains, AssA and AssB, essential for pump assembly and key residues involved in pump assembly, drug recognition, proton translocation and coupling, which are corroborated by mutagenesis and antibiotic sensitivity assays. The delineation of the complete translocation pathway reveals the molecular mechanism for one-step drug transport process across the entire cell envelope.

  • Open Access

    Interactions of a Bacterial RND Transporter with a Transmembrane Small Protein in a Lipid Environment

    by Dijun Du, Arthur Neuberger, Mona Wu Orr, Catherine E. Newman, Pin-Chia Hsu, Firdaus Samsudin, Andrzej Szewczak-Harris, Leana M. Ramos, Mekdes Debela, Syma Khalid, et al.